|
ATP10D expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63002944475465E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.6681100944993E-12 |
| Normal-vs-Stage2 |
4.76509942615166E-11 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
7.099600E-01 |
| Stage1-vs-Stage3 |
7.512500E-02 |
| Stage1-vs-Stage4 |
1.018420E-04 |
| Stage2-vs-Stage3 |
1.495360E-01 |
| Stage2-vs-Stage4 |
3.022700E-03 |
| Stage3-vs-Stage4 |
6.431800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63091762317435E-12 |
| Normal-vs-AfricanAmerican |
2.51280000140852E-08 |
| Normal-vs-Asian |
1.66300306858602E-12 |
| Caucasian-vs-AfricanAmerican |
7.192800E-01 |
| Caucasian-vs-Asian |
7.986600E-01 |
| AfricanAmerican-vs-Asian |
5.897800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62525548574877E-12 |
| Normal-vs-Female |
1.3988810110277E-14 |
| Male-vs-Female |
1.824010E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.65789604267275E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62503344114384E-12 |
| Normal-vs-Age(81-100Yrs) |
2.28719999999516E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.985600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.052200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.868800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.009200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.298800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.456000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.001800E-02 |
| Classical-VS-Follicular |
4.801800E-01 |
| Classical-VS-Other |
8.022200E-01 |
| Classical-VS-Normal |
1.6965318039297E-12 |
| Tall-VS-Follicular |
3.017800E-02 |
| Tall-VS-Other |
4.089000E-01 |
| Tall-VS-Normal |
9.03721542044877E-14 |
| Follicular-VS-Other |
6.751200E-01 |
| Follicular-VS-Normal |
1.86872739504906E-12 |
| Other-VS-Normal |
3.644500E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.7715611723761E-15 |
| Normal-vs-N1 |
8.88178419700125E-16 |
| N0-vs-N1 |
4.190000E-02 |
|
|
